Qing-feng Wang, [email protected] These authors share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
As GLP-1 patches are not yet FDA-approved, they will not be covered by insurance
These multidimensional benefitsphysical, metabolic, and psychologicalexplain why GLP-1 therapy represents a paradigm shift in weight management
GLP-1 Agonistic (Exenatide, Liraglutide) Insulin, Glucagon, Gastric emptying | Weight loss, Nausea 4
La patognesis de la DM1 y la DM2 es drsticamente diferente y, por lo tanto, cada tipo tiene diversas etiologas, presentaciones y tratamientos
Patients should maintain adequate hydration, particularly during the first weeks of treatment, and report persistent abdominal pain, yellowing skin, or rapid heart rate immediately